Shorts aren't shying away from the cannabis industry even after a series of squeezes.
Tilray will have a lot to tackle this evening.
An early look at the market shows supply is finding it tough to keep up with demand.
The stock closed down on its first day of trading on the CSX. Here is a breakdown of the current landscape and some up-and-comers to keep an eye on.
Cannabis and tobacco are hard to equate, which Barclays' primer on the Cannabis industry misses.
The company's intention to list on the NYSE is just one positive it has going for it.
But don't buy into this overheated market right as Canada legalizes, wait until prices come down -- which they will.
These stocks offer some diversification or unique features in the legal-weed space.
There are several avenues to invest in the potential cannabis boom -- recreational plays; medical plays; and companies that have a lot to gain from the industry but aren't reliant upon it for success.
Before you short cannabis names, read this.
While Tilt may be a little harder for some to wrap their heads around, it could pay off for cannabis investors.
Charts for the marijuana stock and the tobacco giant illustrate their different perception among traders.
Sales trends and the potential for stronger versions of prescription cannabis offer medical marijuana providers hope.
The first rule of trading these stocks is to understand and embrace the idea that the shot skyward is just temporary; they WILL crash and burn.
Painkiller manufacturers might see their profits hurt by medical cannabis in the near future.
Expert says weed-related products for pets could become a $55 billion-a-year business.
It also beats Nordstrom and Boston Beer Co.
Intelgenx Technologies soars 115% on non-binding letter of intent to work with Tilray.
The only other option is 'to fearfully wait' for the legal-weed industry to expand.
'There's too much hype too soon,' Canopy Growth chief Bruce Linton says.
Shares were up 94% and down 2.3% in the same session.
Cannabis companies should be taking advantage of the mania to raise money.
A new report indicates only a few dozen institutions have been willing to take the risk of serving marijuana-related businesses in earnest.
Here are 4 stocks to buy to invest in this trend.
The Nasdaq-listed provider of medical marijuana will compete with other firms as Canada opens itself to general adult use of marijuana this fall.
Two companies, PepsiCo and Constellation Brands, are disrupting their own businesses and getting no credit whatsoever for doing so.
Family offices, which manage billions of dollars and have much fewer restrictions on how they deploy capital, have been wading into the cannabis space with increasing frequency.
Even bullish analysts are cautious on Constellation's big cannabis bet.
Odds are good that you'll make at least 8% in 37 days using this put play.
The big banks lend support to the fast-growing cannabis market.